• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

SEMTSI 2017

23-25 October 2017

Bilbao, Spain

X National Congress of Tropical Medicine and International Health

The event aims to guide both tropical medicine and international health. The motto of the 10th edition of the congress was ‘The road to the elimination of NTDs in the 2020 horizon’.

Representatives from DNDi and GARDP took part in the event.

Parallel Sessions

Elimination of helminthiases: medical and epidemiological needs not covered

Date: Monday, October 23, 2017

Massive administration of medicines (MDA): mapping to decide how, what and when 
Jorge Cano, Assistant Professor, London School of Hygiene & Tropical Medecine, England

Onchocerciasis and filariasis: ‘end points’ 
Belén Pedrique, Medical Manager Filarial Disease Programme, DNDi, Geneva

Oral macro-filaricides: rationale and future 
Graeme Bilbe, R&D Director, DNDi, Geneva

Drug Access

Date: Monday, October 23, 2017

Moderators: Maria Romay, ISCIII, Madrid and Jorge Alvar, Head of Disease Area – Leishmaniasis, DNDi, Geneva

The landscape in drug access for NTDs
Margriet den Boer, Doctors Without Borders (MSF), Netherlands

Hepatitis C, alternative strategy
Graciela Diap, DNDi, Geneva

Model for the access, prevention and control of Chagas imported in Spain
Manuel Segovia, Hospital Virgen de la Arrixaca, Spain

Oral medicines in the Horizon 2020 strategy

Date: Tuesday, October 24, 2017

Moderator: Graeme Bilbe, R&D Director, DNDi, Geneva 

A global overview 
Graeme Bilbe, R&D Director, DNDi, Geneva 

Drug resistance in human African trypanosomiasis: past fears, bright future 
Veerle Lejon, Member of WHO Expert Panel on Trypanosomiasis, WHO, Geneva

Chagas: therapeutic and diagnostic perspectives 
Sergio Sosa Estani, Head of Chagas, DNDi Latin America, Brazil

Visceral leishmaniasis, the African void 
Jorge Alvar, Head of Disease Area – Leishmaniasis, DNDi, Geneva
Fabiana Alves, Visceral leishmaniasis Leader, DNDi, Geneva

Resistance to antimicrobials

Date: Tuesday, October 24, 2017

Neonatal sepsis 
Sally Ellis, Neonatal Sepsis Project Leader, GARDP, Geneva 

Typhoid
Isabela Ribeiro, Scientific Dynamic Portfolio Leader, DNDi, Geneva

Sexual transmitted infections 
Emilie Alirol
, Senior Clinical Manager, GARDP, Geneva 

 

Plenary Sessions

Date: Tuesday, October 24, 2017

Global antibiotic research and development

Moderator: Graeme Bilbe, R&D Director, DNDi, Geneva

Speaker
Manica Balasegaram, Director, GARDP, Geneva

Neglected fungal infections

Tuberculosis-like fungal diseases
David Denning, Manchester University & GAFFI, England
Mycetoma, present and future
Ed Zijlstra, DNDi, Geneva
La primera emergencia global por una infección fúngica – Candida auris
Ana Alastruey, ISCIII, Madrid

More information:

  • Meeting website
  • Programme

Other events

Loading...
20 May 2025

Geneva, Switzerland

Strengthening the global ecosystem for paediatric medicines: leadership, collaboration, and impact

21 May 2025

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

7-10 May 2025

Amsterdam, The Netherlands

EASL Congress 2025

20-25 May 2025

Iguaçu Falls, Brazil

22nd ISHAM Congress

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License